REPORT ID 4027

Global Rotavirus Infections Drug Market Research Report 2017

Publish Date
15-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the global Rotavirus Infections Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rotavirus Infections Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Rotavirus Infections Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Beijing Minhai Biotechnology Co Ltd
    Bharat Biotech International Ltd
    Biological E Ltd
    Curevac AG
    Medicago Inc
    Nanotherapeutics Inc
    Serum Institute of India Ltd
    UMN Pharma Inc
    Wuhan Institute of Biological Products Co Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    RV-3BB
    RV-625
    UMN-2001
    Rotavac-5C
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Rotavirus Infections Drug Market Research Report 2017
1 Rotavirus Infections Drug Market Overview
    1.1 Product Overview and Scope of Rotavirus Infections Drug
    1.2 Rotavirus Infections Drug Segment by Type (Product Category)
        1.2.1 Global Rotavirus Infections Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Rotavirus Infections Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 RV-3BB
        1.2.4 RV-625
        1.2.5 UMN-2001
        1.2.6 Rotavac-5C
        1.2.7 Others
    1.3 Global Rotavirus Infections Drug Segment by Application
        1.3.1 Rotavirus Infections Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Rotavirus Infections Drug Market by Region (2012-2022)
        1.4.1 Global Rotavirus Infections Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Rotavirus Infections Drug (2012-2022)
        1.5.1 Global Rotavirus Infections Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Rotavirus Infections Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Rotavirus Infections Drug Market Competition by Manufacturers
    2.1 Global Rotavirus Infections Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Rotavirus Infections Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Rotavirus Infections Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Rotavirus Infections Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Rotavirus Infections Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Rotavirus Infections Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Rotavirus Infections Drug Market Competitive Situation and Trends
        2.5.1 Rotavirus Infections Drug Market Concentration Rate
        2.5.2 Rotavirus Infections Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Rotavirus Infections Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Rotavirus Infections Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Rotavirus Infections Drug Production and Market Share by Region (2012-2017)
    3.3 Global Rotavirus Infections Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Rotavirus Infections Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Rotavirus Infections Drug Consumption by Region (2012-2017)
    4.2 North America Rotavirus Infections Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Rotavirus Infections Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Rotavirus Infections Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Rotavirus Infections Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Rotavirus Infections Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Rotavirus Infections Drug Production, Consumption, Export, Import (2012-2017)

5 Global Rotavirus Infections Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Rotavirus Infections Drug Production and Market Share by Type (2012-2017)
    5.2 Global Rotavirus Infections Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Rotavirus Infections Drug Price by Type (2012-2017)
    5.4 Global Rotavirus Infections Drug Production Growth by Type (2012-2017)

6 Global Rotavirus Infections Drug Market Analysis by Application
    6.1 Global Rotavirus Infections Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Rotavirus Infections Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Rotavirus Infections Drug Manufacturers Profiles/Analysis
    7.1 Beijing Minhai Biotechnology Co Ltd
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bharat Biotech International Ltd
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Biological E Ltd
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Biological E Ltd Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Curevac AG
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Curevac AG Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Medicago Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Medicago Inc Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Nanotherapeutics Inc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Serum Institute of India Ltd
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 UMN Pharma Inc
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 UMN Pharma Inc Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Wuhan Institute of Biological Products Co Ltd
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Rotavirus Infections Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview

8 Rotavirus Infections Drug Manufacturing Cost Analysis
    8.1 Rotavirus Infections Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Rotavirus Infections Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Rotavirus Infections Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Rotavirus Infections Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Rotavirus Infections Drug Market Forecast (2017-2022)
    12.1 Global Rotavirus Infections Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Rotavirus Infections Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Rotavirus Infections Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Rotavirus Infections Drug Price and Trend Forecast (2017-2022)
    12.2 Global Rotavirus Infections Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Rotavirus Infections Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Rotavirus Infections Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Rotavirus Infections Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Rotavirus Infections Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Rotavirus Infections Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Rotavirus Infections Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Rotavirus Infections Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Rotavirus Infections Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer